Compugen Stock Today

CGEN Stock  USD 2.58  0.04  1.57%   

Performance

8 of 100

 
Low
 
High
OK

Odds Of Distress

Less than 11

 
100  
 
Zero
Low
Compugen is selling at 2.58 as of the 29th of March 2024; that is 1.57% increase since the beginning of the trading day. The stock's open price was 2.54. Compugen has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Compugen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of April 2022 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
11th of August 2000
Category
Healthcare
Classification
Health Care
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. The company has 89.53 M outstanding shares of which 1.87 M shares are currently shorted by private and institutional investors with about 2.3 trading days to cover. More on Compugen

Moving together with Compugen Stock

  0.67A Agilent Technologies Earnings Call TodayPairCorr
  0.83EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Compugen Stock

  0.87MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.86VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.84KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.77ME 23Andme HoldingPairCorr
  0.76MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.52MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
  0.49MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Compugen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Compugen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Compugen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEO, DirectorAnat CohenDayag
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Life Sciences Tools & Services, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Compugen report their recommendations after researching Compugen's financial statements, talking to executives and customers, or listening in on Compugen's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Compugen. The Compugen consensus assessment is calculated by taking the average forecast from all of the analysts covering Compugen.
Compugen's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Compugen's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Compugen's financial leverage. It provides some insight into what part of Compugen's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Compugen's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Compugen deploys its capital and how much of that capital is borrowed.
Liquidity
Compugen cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 1.35 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Compugen has a current ratio of 6.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Compugen until it has trouble settling it off, either with new capital or with free cash flow. So, Compugen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Compugen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Compugen to invest in growth at high rates of return. When we think about Compugen's use of debt, we should always consider it together with cash and equity.

Depreciation

452,200
Compugen (CGEN) is traded on NASDAQ Exchange in USA. It is located in Azrieli Center, Holon, Israel, 5885849 and employs 68 people. Compugen is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 227.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugen's market, we take the total number of its shares issued and multiply it by Compugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Compugen conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 89.53 M outstanding shares of which 1.87 M shares are currently shorted by private and institutional investors with about 2.3 trading days to cover. Compugen currently holds about 88.21 M in cash with (35.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.
Check Compugen Probability Of Bankruptcy
Ownership Allocation
Compugen holds a total of 89.53 Million outstanding shares. Compugen shows 5.37 percent of its outstanding shares held by insiders and 13.73 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Compugen Ownership Details

Compugen Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Compugen jumping above the current price in 90 days from now is about 20.37%. The Compugen probability density function shows the probability of Compugen stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.559 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Compugen will likely underperform. Additionally, compugen has an alpha of 0.4423, implying that it can generate a 0.44 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 2.58HorizonTargetOdds Above 2.58
79.55%90 days
 2.58 
20.37%
Based on a normal probability distribution, the odds of Compugen to move above the current price in 90 days from now is about 20.37 (This Compugen probability density function shows the probability of Compugen Stock to fall within a particular range of prices over 90 days) .

Compugen Historical Income Statement

Compugen Income Statement is one of the three primary financial statements used for reporting Compugen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Compugen revenue and expense. Compugen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Compugen's Net Interest Income is very stable compared to the past year. As of the 29th of March 2024, Reconciled Depreciation is likely to grow to about 698.3 K, while Depreciation And Amortization is likely to drop about 452.2 K. View More Fundamentals

Compugen Stock Against Markets

Picking the right benchmark for Compugen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Compugen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Compugen is critical whether you are bullish or bearish towards Compugen at a given time. Please also check how Compugen's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Compugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Compugen Corporate Directors

Compugen corporate directors refer to members of a Compugen board of directors. The board of directors generally takes responsibility for the Compugen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Compugen's board members must vote for the resolution. The Compugen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Joshua ShemerIndependent External DirectorProfile
Ruth ArnonIndependent DirectorProfile
Yair AharonowitzIndependent External DirectorProfile
Michal PremingerDirectorProfile

How to buy Compugen Stock?

Before investing in Compugen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Compugen. To buy Compugen stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Compugen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Compugen stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Compugen stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Compugen stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Compugen, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Compugen Stock please use our How to Invest in Compugen guide.

Already Invested in Compugen?

The danger of trading Compugen is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Compugen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Compugen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Compugen is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
Note that the Compugen information on this page should be used as a complementary analysis to other Compugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Compugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.21)
Revenue Per Share
0.382
Quarterly Revenue Growth
3.461
Return On Assets
(0.08)
Return On Equity
(0.26)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.